# A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B

> **NCT03357822** · PHASE4 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Pegylated interferon
- **DRUG:** Entecavir
- **DRUG:** Tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT03357822
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-25
- **Primary completion:** 2022-01-25
- **Final completion:** 2022-07-25
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2018-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03357822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03357822, "A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03357822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*